Pertussis, a disease caused by the bacterium Bordetella percell pertussis vaccines widely used in the United States was found to be low (36% and 48%) [6, 7] . However, our recent tussis and characterized by a paroxysmal cough phase lasting several weeks, continues to be an important cause of morbidity calculations of the effectiveness of the pertussis vaccination program in the United States, which were made by using the in the United States. A dramatic decline in the incidence of disease was observed following the widespread use of wholescreening method, indicated that the overall effectiveness of three doses of pertussis vaccine against clinical disease was cell pertussis vaccines in the mid-1940s. However, since the early 1980s, the reported incidence of pertussis has been in-82% (95% CI, 79% -85%) [8] . The screening method utilizes data from the national disease surveillance and data on vaccinacreasing, with peaks continuing to occur every 3 -4 years (figure 1) [1] . Large outbreaks were reported in Cincinnati and tion coverage and provides a crude measure of vaccine effectiveness. In this investigation, we were unable to determine Chicago in 1993 and in Idaho, Massachusetts, and Vermont in 1996 [2 -4] . In 1996, 7,796 cases of pertussis were reported, what proportion of children had received vaccine that was shown to have a lower efficacy in the European trials, because the highest number of pertussis cases reported since 1967. This increase in the reported incidence of pertussis occurred surveillance and coverage data did not have information about vaccine manufacturers. in a period when the rate of vaccination coverage among preschool-aged children reached its highest levels in the United Although, in general, pertussis vaccines are highly effective against pertussis disease, immunity following vaccination apStates. The rate of vaccination coverage with at least three doses of diphtheria and tetanus toxoids and whole-cell pertussis pears to wane over time [9 -11] . Waning immunity plays an important role in the occurrence of pertussis in older age vaccine (DTP) increased from 61% in 1991 to 95% in 1995 and 1996 [5] . The rate of vaccination coverage with at least groups. Another possible reason for the increase in the reported incidence of pertussis could be increased diagnosis and refour doses of DTP was 81% in 1996, compared with 59% in 1992. During the same period, in two randomized, controlled porting of cases. Last, a combination of all of the factors listed above could play a role in the increase. Herein, the epidemioltrials conducted in Europe, the efficacy of one of the wholeogy of pertussis in the United States during 1990 -1996 that was based on national surveillance data is described, and possible reasons for the increased reported incidence of pertussis in recent years and the change in age distribution of reported 
Pertussis Vaccination Status
Of the 31,867 cases for which extended information was We used the routine schedule for pertussis vaccination recavailable, 39% were confirmed by a positive laboratory test ommended by the Advisory Committee on Immunization Prac-(culture or PCR assay) or were epidemiologically linked to a tices to determine whether children with pertussis were age laboratory-confirmed case, 44% were probable, and 17% were appropriately vaccinated at the time of onset of pertussis [15] .
neither probable nor confirmed but had cough illness. The primary series for pertussis vaccination consists of three Results of nasopharyngeal cultures for B. pertussis were doses administered at ages 2, 4, and 6 months. Booster doses reported to CDC for 16,895 persons, of whom 11,426 (68%) are recommended at ages 15 -18 months and 4 -6 years. If at had a positive result. The proportion of positive cultures deleast 6 months have elapsed since the third dose, a child who clined by age group; B. pertussis was isolated from 75% of is not likely to return for a visit at the recommended age can 8,378 children aged younger than 1 year, 67% of 3,280 children be vaccinated as early as 12 months of age. During 1990 -aged 1 -4 years, 61% of 1,692 persons aged 5 -9 years, 59% 1996, DTP was used widely for the primary series and booster of 2,253 persons aged 10 -19 years, and 47% of 1,278 persons doses. Since 1991, two formulations of acellular pertussis vacaged 20 years or older. cine combined with diphtheria and tetanus toxoids (DTaP) have Overall in the states other than Massachusetts, the proportion been licensed for use as booster doses. Since July 1996, four of nasopharyngeal specimens collected in the first 10 days of formulations of DTaP have been licensed for use in the primary cough illness from persons aged 10 years or older has not series, and DTaP is now recommended for both the primary changed; however, in Massachusetts, since 1994 the proportion series and booster doses [15] .
has increased (40% in 1994; 54% in 1995; and 77% in 1996). During this period, the proportion of culture-positive cases
Analytical and Statistical Methods
among persons tested who were aged 10 years or older increased from 49% in 1994 to 81% in 1995 and 96% in 1996. Until 1996, data from different surveillance systems were PCR assay was performed on specimens from 360 patients compiled separately, and no attempts were made to match cases (94% of cases were from 1996). Of these specimens, 280 (78%) from separate systems. Demographic information was obtained were positive. The proportion of patients for whom PCR assays from NETSS data. For information on symptoms, vaccination were positive decreased with increasing age: 93% of patients history, and laboratory findings, SPSS data were used. Howaged younger than 1 year, 74% of patients aged 1 -4 years, ever, because in 1996 it became possible to report the extended 83% of patients aged 5 -9 years, 67% of patients aged 10 -19 information from the same case to both the new NETSS exyears, and 47% of patients aged 20 years or older. tended electronic screen and SPSS, 1996 data from both SPSS Of the 52 cases that were excluded from the analysis because and the extended electronic screen were concatenated, and duof absence of cough, 18 were culture-positive. Of the 18 perplicates (identified by comparing date of birth, date of cough sons for whom cultures were positive, 3 (16%) were aged onset, sex, and county and state of report) were deleted.
younger than 1 year, 1 (6%) was aged 1 -4 years, 5 (28%) Except for calculation of the age-specific incidence of pertuswere aged 5 -9 years, and 9 (50%) were aged 10 years or older. sis, results were not extrapolated to include missing data. To These people were identified during investigation of contacts. maintain consistency with previously published reports [1, 16] ,
The duration of culture positivity was not investigated. two groups of cases were excluded from analysis: all cases reported to either surveillance system from Puerto Rico and other U.S. territories (n Å 9) and cases without cough (n Å 52).
Age of Patients
To assess the age distribution of cases reported by different Children aged younger than 1 year accounted for the highest states in 1996, states were divided into two groups: states that proportion of cases reported during 1990 -1996. However, the reported high incidences of pertussis (i.e., §2 cases per proportion of cases in this age group decreased over time. 100,000 population in §4 years between 1990 and 1996) and Forty-four percent of the persons whose cases were reported all the remaining states. The proportion of cases in different during 1990 -1993 were aged younger than 1 year, and 22% age groups was compared between the two groups.
were aged 1 -4 years ( and a 4% decrease among patients aged 1 -4 years. Although greater in older age groups. For example, among children aged younger than 10 years, the incidence was 8.2 cases per 100,000 the proportion of cases in children aged 5 -9 years was similar during 1990 -1993 and 1994 -1996, the incidence increased population among females and 7.9 cases per 100,000 population among males. Incidences among older females and males, 40%. The highest increase (106%) was observed among persons aged 10 years or older, and the incidence among persons respectively, were as follows: persons aged 10 -19 years, 2.6 cases per 100,000 population vs. 2.1 cases per 100,000 populaaged 20 years or older almost doubled (93%).
Most (82%) of the infants (i.e., younger than 1 year of age) tion; persons aged 20 -39 years, 0.6 case per 100,000 population vs. 0.3 case per 100,000 population; and persons aged 40 whose cases were reported during 1990 -1996 were aged younger than 6 months, an age group for whom primary pertusyears or older, 0.3 case per 100,000 population vs. 0.2 case per 100,000 population. sis vaccination with three doses is incomplete. Thirty-five percent of the cases in infants occurred in children aged younger than 2 months who were too young to have received any pertusVaccination Status sis vaccine.
Of 10,617 children aged 3 months to 4 years who had reported cases of pertussis and known vaccination status, 5,008 Sex (47%) had not been vaccinated age appropriately against perOverall, reported incidences among females and males were tussis: 2,680 children (25%) had received no doses of pertussis similar (1.8 and 1.7 cases per 100,000 population, respectively), vaccine. Of 6,828 children aged 7 months to 4 years, 3,353 although the ratio of incidences among females and males was (49%) had not received at least three doses of pertussis vaccine, the minimal number of doses considered necessary for optimal protection against pertussis. Of 1,317 children between 5 and 6 years of age, 707 (54%) had not received the recommended four or more doses of pertussis vaccine, 643 (49%) had not received three doses (i.e., the primary series), and 422 (32%) had received no doses (table 2) .
Clinical Characteristics
Sixty-one percent of infants and 76% of patients aged 10 years or older had cough durations of §21 days. The proportion of cases with paroxysmal cough was high in all age groups (e.g., 90% of patients aged younger than 5 years and 86% of patients aged 20 years or older). Vomiting, whoop, and apnea, each reported in ú55% of cases in patients aged younger than 1 year, decreased in frequency with increasing age. Of the adults aged 20 years or older who had reported cases, 43% 
Geographic Distribution
Seizures were described in 418 patients, encephalopathy was described in 70 patients, and 57 deaths were attributed to perPertussis cases were reported from all 50 states and the tussis. Patients aged younger than 6 months had the highest District of Columbia during 1990 -1996. However, the reported rate of complications: 72.2% were hospitalized, 17.3% were annual incidence of pertussis varied greatly between states. reported to have had pneumonia, and 2.1% were reported to Certain states repeatedly reported higher incidences of pertussis have had seizures (compared with 46%, 14.8%, and 2% of than did others. For example, 14 states (Arizona, Colorado, patients aged 6 -11 months, respectively, during the same peHawaii, Idaho, Massachusetts, Minnesota, New Hampshire, riod). The proportion of complications declined markedly with New Mexico, New York, Oregon, Utah, Vermont, Washington, increasing age.
and Wisconsin) reported incidences of §2 cases per 100,000 The proportion of patients hospitalized, in particular those population for §4 years during 1990 -1996. Florida, Georgia, older than 6 months of age, decreased over time. In 1990, 47% Louisiana, Mississippi, New Jersey, and West Virginia reported of patients aged 6 -11 months, 22% of patients aged 1 -4 years, the lowest incidences throughout the period. 12% of patients aged 5 -9 years, 7% of patients aged 10 - 19 The proportion of patients with reported cases who were years, and 5% of patients aged 20 years or older were hospitaladolescents (i.e., 10 -19 years of age) and adults varied between ized. In 1996, these proportions were 37%, 14%, 4%, 2%, and 3%, respectively. states as well. In nine states (Arizona, Colorado, Idaho, Mary- * Based on persons for whom age and clinical data were reported. † Radiographically confirmed. ‡ Excludes 28 patients (0.001%) whose ages were unknown. § Excludes seven hospitalized patients (0.001%) whose ages were unknown. Data on hospitalization were not reported for 431 patients (0.01%).
x Excludes one patient with pneumonia (0.00003%) whose age was unknown. Data on pneumonia were not reported for 3,005 patients (9.5%). # Data on seizures, encephalopathy, and outcome were not reported for 1,419 patients (4.4%), 814 patients (2.6%), and 142 patients (0.005%), respectively.
/ 9c68$$ju03 05-21-99 13:09:34 cida UC: CID mated that only 11.6% of pertussis cases were reported to CDC [17] . Underreporting of pertussis cases, because of a lack of typical pertussis symptoms such as whoop, may be higher for adolescents and adults than for young children. In addition, low yields of cultures of specimens from patients in this age group (due to previous vaccination, late specimen collection, and antibiotic use) may result in fewer diagnoses of pertussis and underestimation of the true incidence; however, intensified surveillance efforts and health care providers' increased awareness of pertussis in adolescent and adult patients may be contributing factors to the increased reporting of cases in this age group in recent years. The decreased proportion of hospitalized this age group. National surveillance data indicate that the incidence of pertussis and the proportion of cases in adolescents and adults land, Massachusetts, New Hampshire, North Carolina, Vervary greatly among states. Those states that report higher promont, and Wisconsin), the proportion of cases in adolescents portions of cases in the older age group also report high inciand adults was §25% during §4 years in 1990 -1996. Except dences of pertussis, and certain states consistently report higher for North Carolina and Maryland, all of these states were also incidences of pertussis than do others. The reasons for this among those 14 states that reported high incidences of pertussis pattern are unclear; however, these data suggest that completeduring this period.
ness of reporting may not be similar in all states. In states in The proportion of cases in different age groups was comwhich surveillance efforts have been intensified, milder cases pared between two groups of states: those 14 states that reported in adolescents and adults may be detected and reported. Such incidences of §2 cases per 100,000 population for §4 years efforts appear to have a role in the high incidence of cultureduring 1990 -1996 and the remaining 36 states that reported confirmed pertussis that was described among adolescents in incidences of õ2 cases per 100,000 population for §4 years Vermont in 1996 [4] . Serological diagnosis (as practiced in during the same period. Although 58% of the cases reported Massachusetts [18] ), which is not widely available in most in the 14 states occurred in persons aged 5 years or older, in states, had an impact on the reported number of cases, espethe rest of the states only 29% of all cases reported were in cially in adolescents and adults. However, in recent years there this age group. More than one-half of the cases reported in has been an increase in the reported number of culturestates with low incidences occurred in infants.
confirmed cases in adolescents and adults as well. Since 1994, an increase in the proportion of nasopharyngeal specimens collected in the first 10 days of cough illness from persons aged Seasonality 10 years or older has been noted. This increase may have been During 1990 -1996, cases occurred in all seasons, but variadue in part to a letter sent out in mid-1995 by the Massachusetts tion in the occurrence of cases was seen when cases in different State Laboratory Institute that requested physicians to submit age groups were analyzed. In general, reported pertussis cases only specimens collected within 2 weeks of cough onset. This in children aged younger than 5 years and adults aged 20 years practice and extensive contact investigation during school outor older peaked between June and September (figure 3), and breaks may have increased the proportion of specimens colcases in persons aged 5 -19 years peaked between October and lected in the early phase of disease. To better understand December (i.e., the first few months of the school year).
whether incidences of pertussis in different states are a result of detection and reporting differences, surveillance activities need to be enhanced in states that report low incidences of Discussion pertussis as well. The limited data available on the duration of pertussis vacSimilar to what occurred during the 1980s, the incidence of pertussis increased progressively during 1990 through 1996, cine -induced immunity suggest that vaccinated persons become susceptible to pertussis disease Ç5 -10 years following with peaks occurring every 3 years. The increase in incidence, in particular since 1993, has been mainly due to the substantial vaccination [9 -11] . It is also possible that the rate at which vaccine-induced immunity wanes may vary depending on the increase in the number of reported cases in persons aged 10 years or older. During 1994 -1996, the incidence among pertype or brand of vaccine. Waning immunity likely plays a role in the increasing incidence of pertussis among persons aged sons in this age group doubled compared with the incidence during 1990 -1993 In conclusion, the increase in the reported incidence of perthey are administered to adults [19 -23] . A randomized, controlled study supported by the National Institutes of Health is tussis in recent years is mainly due to an increase in the number of reported cases in persons aged 10 -19 years. Several factors under way to evaluate the safety and efficacy of an acellular pertussis vaccine for adolescents and adults. may contribute to this increase, such as improved reporting of pertussis cases (especially in some states) and use of diagnostic In recent years, the incidence of pertussis among infants and young children has remained relatively stable in the United methods that are more sensitive than culture. To understand the true burden of disease in adolescents and adults, active States. Most of the cases in infants occurred in those too young to complete the primary series with three doses of pertussis surveillance is needed in different areas of states with low and high incidences as well as enhanced surveillance activities, in vaccine. The relatively stable incidence among infants and young children may be due to high rates of vaccination coverparticular, in those states that report low incidences. In the near future, acellular pertussis vaccines may be licensed for use for age in the United States since the early 1990s. Pertussis outbreaks in populations of children for whom the rate of vaccinapersons 7 years of age or older in the United States. These new vaccines may have a role in the prevention of disease and tion coverage is high have been reported [2] . It is expected that the proportion of cases in vaccinated persons will increase control of outbreaks in adolescents and adults. as the rate of vaccination coverage increases [24] . In comparison with 1980 -1989, the proportion of patients who had re-and immunity to pertussis has not been established, serology 
